Why single blood values are not sufficient for Longevity

15.11.2024
Our Co-Authors:
Author:
Co-Founder & Medical Director
Medical Consultant
Table of contents

Blood tests are a common diagnostic tool for health. They provide a snapshot of health status, but when it comes to longevity diagnostics, a single blood value is simply not enough. Understanding longevity requires a broader, data-driven, and holistic approach.

The case for comprehensive Longevity diagnostics

Why holistic diagnostics matter  

At the center of longevity is the concept of personalized medicine. We now understand that every person is unique, and no two people carry the same risk of chronic health conditions. An entire range of factors, including genetics, lifestyle, and environment, determines the level of risk. 

Clinical laboratories have created the concept of reference intervals (RI) to define normal ranges for blood results. RI were developed using samples from clinical trials to identify the ranges of a “normal or healthy” population. The suggestion was that any figures that were outside of this normal range would indicate disease or the risk of disease. 

However, with an increase in understanding of the uniqueness of individual blood tests we have to ask how do we define “normal”? 

It’s been shown that there is a 5% rate of healthy individuals who will still sit outside of “normal” RI ranges [1]. Not only that, but the more tests that are conducted the higher the chance that a result will fall outside of this normal range. This proves that a standalone diagnostic test is not optimal, especially for the need for prevention.

As the averages for population health change over time, there is a growing difference between what is ‘normal’ and what is optimal.

There are thousands of biomarkers [2] that can now be tested for, and each one adds to the puzzle of a person’s unique biological profile. In the scientific literature, some blood biomarkers associated with improved longevity are not routinely tested in labs. Those biomarkers assess different aspects of cardiovascular health and lipid profile (ApoB, Asymmetric Dimethylarginine -ADMA ), metabolic health and insulin resistance (HOMA index), and oxidative stress (Glutathione). 

Beyond blood tests: a holistic view of Longevity

Why a single blood value can’t tell the whole Story  

A complex interplay of genetics, lifestyle, environment, and disease risk factors influences longevity. Each of these components affects your body in ways that no single blood test can capture. 

In order to maintain health for longer, we want to be able to have the most accurate prediction of your health status, therefore identifying trends that could ultimately lead to the manifestation of diseases. 

Blood biomarkers are very important for giving a current snapshot of your health, and looking into context together with other biomarkers can give a much more comprehensive view and inform the best strategy for your longevity. For instance, you might have normal blood sugar levels but still be at risk for long-term complications like cognitive decline or joint problems. Even with healthy cholesterol levels, you could be at risk for falls, fractures, or reduced mobility as you age. In other words, while blood tests provide valuable data, they don't give a comprehensive view of a person’s overall health trajectory.

Health challenges like fractures, falls, or loss of mobility often arise in older age, but the steps to prevent them must begin decades earlier. For instance, while osteoporosis (a decrease in bone mineral density) typically starts around age fifty, the processes contributing to it can begin much sooner.

Long-term health risks, such as cardiovascular and metabolic diseases, are among the most common causes of illness. These conditions often develop silently, with damage occurring years before any symptoms are noticed. While blood tests can identify certain biomarkers and risks early, they are not enough on their own. Diseases like osteoporosis and cardiovascular conditions require more than just simple blood tests for proper detection. Comprehensive diagnostics, combining blood values with other tests, are necessary to catch these risks early and allow for timely prevention.

Health optimization

The benefit of comprehensive testing, in addition to blood biomarkers, is that we are aiming for prevention over cure. Understanding how your body works and what some of your weak points are can help us determine the best-personalized strategy for you. 

A more holistic approach involves assessing multiple factors, including physical performance, mental health, genetic predispositions, and lifestyle habits like diet and exercise. This comprehensive evaluation offers a more accurate prediction of longevity and a strategy for optimal health. That can include personalized nutrition plans, targeted supplementation, the right exercise program, and innovative treatments that can improve your health on a cellular level. Using multiple biomarkers besides blood, we can track your health over time and follow its dynamic by adapting your longevity protocols and health strategy.

The power of data in personalized Longevity plans

Modern medicine is moving toward more comprehensive diagnostic methods that look beyond blood tests. Advances in genetic testing, microbiome analysis, and wearable technology allow for real-time monitoring of health parameters like heart rate variability, sleep patterns, and physical activity levels. These tools can provide insights into how well your body is functioning on a day-to-day basis, offering predictive markers that can be even more telling than static blood values. Additionally, biomarkers related to inflammation, oxidative stress, and telomere length—none of which are typically measured in routine blood tests—can provide valuable insights into aging and disease risks. Inflammation, for instance, plays a major role in chronic diseases like arthritis, heart disease, and dementia, but it’s not something that can be diagnosed purely from standard blood tests. Assessing inflammatory markers and combining them with other health data offers a clearer view of long-term health risks.

The integration of these multiple diagnostic approaches offers a way to understand the unique factors affecting each person’s health. Rather than relying on broad population averages, personalized assessments can identify which areas of health need improvement, allowing for interventions that are specifically tailored to the individual. For example, someone with a genetic predisposition to osteoporosis might benefit from specific strength training exercises and nutritional supplements, even if their bone density is currently within a healthy range.

Comprehensive health checks, including body composition screening and extended blood analysis, not only utilize cutting-edge technology, they’re also data-driven and backed by science. 

Personalized medicine is emerging as a powerful approach to understanding and improving longevity. By taking into account genetic information, environmental exposures, and individual lifestyle factors, personalized health assessments can offer tailored recommendations for maintaining health and extending lifespan. Blood tests play a role in this, but so do genetic screenings, epigenetic analyses, and lifestyle assessments.

Conclusion: Blood values are just one part of the puzzle

While blood tests are a useful diagnostic tool, they don’t tell the full story of your health. By using comprehensive diagnostics and tracking key biomarkers, you can optimize your health, maintain athletic performance, and improve your chances of a long, healthy life.

Ready to take control of your health? 

Book your comprehensive Longevity Check at AYUN today and start your journey to optimal health.

References
  1. Timbrell N. E. (2024). The Role and Limitations of the Reference Interval Within Clinical Chemistry and Its Reliability for Disease Detection. British journal of biomedical science, 81, 12339. https://doi.org/10.3389/bjbs.2024.12339
  1. Wishart, D. S., Bartok, B., Oler, E., Liang, K. Y. H., Budinski, Z., Berjanskii, M., Guo, A., Cao, X., & Wilson, M. (2021). MarkerDB: an online database of molecular biomarkers. Nucleic acids research, 49(D1), D1259–D1267. https://doi.org/10.1093/nar/gkaa1067
  1. Moqri, M., Herzog, C., Poganik, J. R., Biomarkers of Aging Consortium, Justice, J., Belsky, D. W., Higgins-Chen, A., Moskalev, A., Fuellen, G., Cohen, A. A., Bautmans, I., Widschwendter, M., Ding, J., Fleming, A., Mannick, J., Han, J. J., Zhavoronkov, A., Barzilai, N., Kaeberlein, M., Cummings, S., … Gladyshev, V. N. (2023). Biomarkers of aging for the identification and evaluation of longevity interventions. Cell, 186(18), 3758–3775. https://doi.org/10.1016/j.cell.2023.08.003
  1. Anderson, E., & Durstine, J. L. (2019). Physical activity, exercise, and chronic diseases: A brief review. Sports Medicine and Health Science, 1(1), 3-10. https://doi.org/10.1016/j.smhs.2019.08.006
  1. McPhee, J. S., French, D. P., Jackson, D., Nazroo, J., Pendleton, N., & Degens, H. (2016). Physical activity in older age: perspectives for healthy ageing and frailty. Biogerontology, 17(3), 567–580. https://doi.org/10.1007/s10522-016-9641-0